✦ LIBER ✦

Cardiovascular risk assessment in patients with type 2 diabetes mellitus and metabolic syndrome: Role of biomarkers

✍ Scribed by Gungor Kanbak; Aysen Akalin; Ali Dokumacioglu; Eda Ozcelik; Cengiz Bal

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

126 CARDIOVASCULAR RISK IN PATIENTS WITH

✍ Millan, J.; Calzado, C. Garcia; Recarte, C. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Dalcetrapib in High-Risk Patients with T

✍ Michael H. Davidson; Anton F.H. Stalenhoef; Jennifer G. Robinson; Regina Duttlin 📂 Article 📅 2009 🏛 Elsevier 🌐 English ⚖ 37 KB

8 hs-PCR and cardiovascular risk in type

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 157 KB

Laparoscopic treatment of metabolic synd

✍ A. L. DePaula; A. L. V. Macedo; N. Rassi; S. Vencio; C. A. Machado; B. R. Mota; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 312 KB

Laparoscopic treatment of metabolic synd

✍ A. L. DePaula; A. L. V. Macedo; N. Rassi; S. Vencio; C. A. Machado; B. R. Mota; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 312 KB

Sex-Specific differences in metabolic co

✍ Alexandra Kautzky-Willer; Majid Reza Kamyar; Dora Gerhat; Ammon Handisurya; Guna 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 143 KB